| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $940.2M | +25.7% |
| Cost of Revenue | $450.6M | +18.6% |
| Gross Profit | $489.6M | +33.1% |
| R&D Expense | $198.9M | +17.2% |
| SG&A Expense | $389.8M | +10.6% |
| Operating Income | -$99.1M | +57.5% |
| Pre-tax Income | -$91.9M | +58.3% |
| Income Tax | $4.2M | +76.3% |
| Net Income | -$96.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.2M | +17.6% |
| Short-term Investments | $369.1M | -9.8% |
| Accounts Receivable | $114.6M | +8.6% |
| Inventory | $149.6M | -5.3% |
| Current Assets | $724.5M | -3.1% |
| Total Assets | $967.7M | +1.6% |
| Current Liabilities | $247.0M | +26.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.2M | +176.2% |
| Capital Expenditures | $19.2M | -28.3% |
| Investing Cash Flow | -$23.5M | +72.6% |
| Financing Cash Flow | $8.4M | +103.4% |
| Free Cash Flow | $5.0M | +108.5% |
| +56.9% |
| EPS (Basic) | -$1.47 | +57.1% |
| EPS (Diluted) | -$1.47 | +57.1% |
| Long-term Debt |
| $308.3M |
| +8.2% |
| Total Liabilities | $704.6M | +10.3% |
| Stockholders' Equity | $263.1M | -16.1% |